Bounce from ConsolidationEris Lifesciences looking good, seeing a bounce after a consolidation.
CMP 1630
SL: 1580
Can expect levels of 1700-1840
Long
Eris Lifesciences Ltd
No trades
No trades
Compare with Eris Lifesciences Ltd
47.0 INR
6.20 B INR
31.29 B INR
44.36 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Amit Indubhushan Bakshi
Website
Headquarters
Ahmedabad
Founded
2007
IPO date
Jun 29, 2017
ISIN
INE406M01024
FIGI
BBG00GX73BH6
Identifiers
ISIN INE406M01024
Eris Lifesciences Ltd. engages in the provision of pharmaceutical products. Its brands include Eritel, Glimsave, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The firm markets and distributes pharmaceutical drugs, such as tablets, syrups and injections. The company was founded by Amit Indubhushan Bakshi on January 25, 2007 and is headquartered in Ahmedabad, India.
Long
ERIS - Bullish Momentum Revival💹 Eris Lifesciences Ltd (NSE: ERIS)
Sector: Pharmaceuticals | CMP: 1701.30 | View: Bullish Momentum Revival
Chart Pattern: Falling Wedge Pattern
Candlestick Pattern: Strong Bullish Momentum Candle
Swing High: 1910
Swing Low: 1506
Price Action
Eris Lifesciences has delivered a decisive shift in stru
Long
BUY TODAY SELL TOMORROW for 5%DON’T HAVE TIME TO MANAGE YOUR TRADES?
- Take BTST trades at 3:25 pm every day
- Try to exit by taking 4-7% profit of each trade
- SL can also be maintained as closing below the low of the breakout candle
Now, why do I prefer BTST over swing trades? The primary reason is that I have observed that
ERIS 1 Day View 📊 Current Price & Range
Last traded around ₹1,669 – ₹1,672
Today’s observed intraday range so far: Low ~ ₹1,651.6 and High ~ ₹1,679.2.
Previous close was ~ ₹1,669.60.
🔍 Key Technical Levels (1-Day)
Support levels to monitor:
1. ~ ₹1,650 mark – near today’s intraday low (~1,651).
2. A stronger b
Long
Eris Lifesciences Ltd: Symmetrical Triangle FormationEris Lifesciences Ltd . is currently exhibiting a Symmetrical Triangle Pattern on its daily chart. This pattern is characterized by converging trendlines formed by lower highs and higher lows, indicating a period of consolidation. While symmetrical triangles often serve as continuation patterns, t
ERIS LIFESCIENCE broken out in rectangular patternERIS LIFESCIENCE broken out in 10 months rectangular pattern and poised for quick momentum if sustain above 1560
Long
Amazing breakout on WEEKLY Timeframe - ERISCheckout an amazing breakout happened in the stock in Weekly timeframe, macroscopically seen in Daily timeframe. Having a great favor that the stock might be bullish expecting a staggering returns of minimum 25% TGT. IMPORTANT BREAKOUT LEVELS ARE ALWAYS RESPECTED!
NOTE for learners: Place the break
Long
ERIS Life Science - Rectangle Pattern near All Time High1. Pattern Analysis
ERIS Lifesciences is currently presenting a compelling bullish structure through the formation of a Rectangle Pattern that has evolved over a 10-month period. This horizontal consolidation structure is formed by consistent reactions from the upper resistance zone around ₹1,510 a
Long
ERIS Lifesciences Share Price AnalysisEris Lifesciences is currently trading in the range of ₹1,371 to ₹1,474, with the latest reported price at ₹1,474.20 as of April 23, 2025. The stock has shown strong performance over the past year, delivering a return of approximately 57%. Over the last three months, the stock is up about 9%, though
Long
ERIS LifesciencesDate 08.03.2025
ERIS Lifesciences
Timeframe = Weekly Chart
Technical Remarks :
1 Currently under corrective phase of wave 4. A three wave pattern.
2 Neckline at 1203
3 Next swing support/breakdown areas are 1203 / 1141 / 1036 (100%) & 1108 (38%)
4 If someone is under long position keep neckline
See all ideas
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Weight0.05%
Market value32.65 K
Weight0.32%
Market value27.85 K
Weight0.08%
Market value7.43 K
Explore more ETFs
Frequently asked questions
The current price of ERIS is 1,170.7 INR — it has increased by 1.35% in the past 24 hours. Watch Eris Lifesciences Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Eris Lifesciences Ltd stocks are traded under the ticker ERIS.
ERIS stock has fallen by −0.90% compared to the previous week, the month change is a −11.18% fall, over the last year Eris Lifesciences Ltd has showed a −27.51% decrease.
We've gathered analysts' opinions on Eris Lifesciences Ltd future price: according to them, ERIS price has a max estimate of 1,780.00 INR and a min estimate of 1,240.00 INR. Watch ERIS chart and read a more detailed Eris Lifesciences Ltd stock forecast: see what analysts think of Eris Lifesciences Ltd and suggest that you do with its stocks.
ERIS reached its all-time high on Jun 12, 2025 with the price of 1,910.0 INR, and its all-time low was 321.0 INR and was reached on Mar 13, 2020. View more price dynamics on ERIS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ERIS stock is 2.74% volatile and has beta coefficient of 0.57. Track Eris Lifesciences Ltd stock price on the chart and check out the list of the most volatile stocks — is Eris Lifesciences Ltd there?
Today Eris Lifesciences Ltd has the market capitalization of 162.69 B, it has decreased by −0.21% over the last week.
Yes, you can track Eris Lifesciences Ltd financials in yearly and quarterly reports right on TradingView.
Eris Lifesciences Ltd is going to release the next earnings report on Nov 11, 2026. Keep track of upcoming events with our Earnings Calendar.
ERIS earnings for the last quarter are 10.30 INR per share, whereas the estimation was 10.77 INR resulting in a −4.33% surprise. The estimated earnings for the next quarter are 10.78 INR per share. See more details about Eris Lifesciences Ltd earnings.
Eris Lifesciences Ltd revenue for the last quarter amounts to 8.73 B INR, despite the estimated figure of 8.63 B INR. In the next quarter, revenue is expected to reach 8.93 B INR.
ERIS net income for the last quarter is 1.42 B INR, while the quarter before that showed 2.82 B INR of net income which accounts for 0.00% change. Track more Eris Lifesciences Ltd financial stats to get the full picture.
Eris Lifesciences Ltd dividend yield was 0.00% in 2025, and payout ratio reached 0.00%. The year before the numbers were 0.52% and 28.43% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 11, 2026, the company has 3.08 K employees. See our rating of the largest employees — is Eris Lifesciences Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Eris Lifesciences Ltd EBITDA is 11.40 B INR, and current EBITDA margin is 36.16%. See more stats in Eris Lifesciences Ltd financial statements.
Like other stocks, ERIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eris Lifesciences Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eris Lifesciences Ltd technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eris Lifesciences Ltd stock shows the sell signal. See more of Eris Lifesciences Ltd technicals for a more comprehensive analysis.